glp-1 shortage update Ro launches supply tracker to help patients navigate shortages Taking Stock: What Ro's GLP-1

Roche reported ~CHF 61.5 billion ($78.6 billion) in total sales, driven by strong pharmaceuticals growth, though Roche does not break out standalone revenue for Genentech publicly

Leveraging large-scale biobank EHRs to enhance pharmacogenetics of cardiometabolic disease medications

Tirzepatide slows gastric emptying, which means alcohol stays in your stomach longer, gets absorbed more slowly, but produces more prolonged intoxication effects

However, due to the nausea often associated with these drugs, initiating treatment at a lower dose and gradually increasing it can improve tolerability

Alcohol Alcohol can be tricky on its own for people with diabetes, but GLP-1 medications add another layer